Limax Biosciences
PrivateLast Round
Grant
Oct 1, 2025
Total Funding Raised
$200,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Limax Biosciences operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was an Angel round in March 2025.
Limax Biosciences is a therapeutic devices company that develops a degradable adhesive hydrogel for hemostasis, wound closure, and drug delivery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Limax Biosciences Comparables
Compare Limax Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AsparaGlue | 84% | |
| Sealonix, Inc. | 82% | |
| Cresilon | 78% |
For institutional investors. Book with your work email.
Limax Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 1, 2025 | ||||
| Angel | Mar 25, 2025 | ||||
| Accelerator | Feb 16, 2023 | ||||
| Grant | Sep 1, 2022 | ||||
| Accelerator | Jun 7, 2022 | ||||
Grant | May 5, 2022 |
For institutional investors. Book with your work email.
Limax Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Accelerator |
| Catalytic Impact Foundation | Angel |
| MassChallenge Israel | Accelerator |
| Johnson & Johnson Innovation - JLABS | Accelerator |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Grew 57% QoQ from 7 to 11 employees.
- Jun 25, 2026
Grew 117% QoQ from 6 to 13 employees.
For institutional investors. Book with your work email.
Limax Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Limax Biosciences's valuation, stock price, and market status.
Is Limax Biosciences a public or private company?
Limax Biosciences is a private company.
What is the current stock price of Limax Biosciences?
Limax Biosciences is a private company, so its shares have no public market price. Caplight tracks Limax Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Limax Biosciences worth (valuation)?
Valuation information for Limax Biosciences is not publicly available.
Can I buy Limax Biosciences stock?
Limax Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Limax Biosciences's last funding round?
Limax Biosciences's most recent funding round was Grant on October 1, 2025.
Who are the main investors in Limax Biosciences?
Key investors in Limax Biosciences include Catalytic Impact Foundation.
Will Limax Biosciences IPO soon?
No public IPO plans have been announced for Limax Biosciences.
How can I track Limax Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Limax Biosciences's shares on secondary markets.